Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update

被引:117
作者
Bioulac-Sage, P. [1 ]
Balabaud, C. [1 ]
Bedossa, P. [1 ]
Scoazec, J. Y. [1 ]
Chiche, L. [1 ]
Dhillon, A. P. [1 ]
Ferrell, L. [1 ]
Paradis, V. [1 ]
Roskams, T. [1 ]
Vilgrain, V. [1 ]
Wanless, I. R. [1 ]
Zucman-Rossi, J. [1 ]
机构
[1] CHU Bordeaux, Hop St Andre, Serv Hepatol Gastroenterol, Bordeaux, France
关键词
D O I
10.1016/j.jhep.2006.12.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Pathological diagnosis of liver cell adenoma, hepatocellular adenoma (HCA), and focal nodular hyperplasia (FNH) is discussed. HCA is a rare tumor, presenting in a variety of clinical settings, which cannot be identified conclusively by any currently available imaging technique. FNH has been reported in 0.6-3% of the general population and is 10 times more frequently observed than adenomas in referral centers. The examination of a liver biopsy or resection specimen remains the standard practice to establish the diagnosis of HCA and FNH when radiographic investigations have failed to establish a definitive diagnosis. The optimal care of patients with liver nodule requires the combined expertise of hepatologists, pathologists, radiologists, and surgeons. development of more readily available immunobiological tools will permit significant improvements in the liver biopsy interpretation in the ability to distinguish HCA and FNH.
引用
收藏
页码:521 / 527
页数:7
相关论文
共 52 条
  • [1] ANTHONY PP, 2002, PATHOLOGY LIVER, P711
  • [2] Rapid disappearance of hepatic adenoma after contraceptive withdrawal
    Aseni, P
    Sansalone, CV
    Sammartino, C
    Di Benedetto, F
    Carrafiello, G
    Giacomoni, A
    Osio, C
    Vertemati, M
    Forti, D
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (03) : 234 - 236
  • [3] Familial liver adenomatosis associated with hepatocyte nuclear factor 1α inactivation
    Bacq, Y
    Jacquemin, E
    Balabaud, C
    Jeannot, E
    Scotto, B
    Branchereau, S
    Laurent, C
    Bourlier, P
    Pariente, D
    De Muret, A
    Fabre, M
    Bioulac-Sage, P
    Zucman-Rossi, J
    [J]. GASTROENTEROLOGY, 2003, 125 (05) : 1470 - 1475
  • [4] Belghiti J, 2005, HEPATOLOGY, V42, p296A
  • [5] Bioulac-Sage P, 2005, HEPATOLOGY, V42, p300A
  • [6] Diagnosis of focal nodular hyperplasia - Not so easy
    Bioulac-Sage, P
    Balabaud, C
    Wanless, IR
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) : 1322 - 1325
  • [7] Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver
    Bioulac-Sage, P
    Rebouissou, S
    Cunha, AS
    Jeannot, E
    Lepreux, S
    Blanc, JF
    Blanché, H
    Le Bail, B
    Saric, J
    Laurent-Puig, P
    Balabaud, C
    Zucman-Rossi, J
    [J]. GASTROENTEROLOGY, 2005, 128 (05) : 1211 - 1218
  • [8] Bi-allelic inactivation of TCF1 in hepatic adenomas
    Bluteau, O
    Jeannot, E
    Bioulac-Sage, P
    Marqués, JM
    Blanc, JF
    Bui, H
    Beaudoin, JC
    Franco, D
    Balabaud, C
    Laurent-Puig, P
    Zucman-Rossi, J
    [J]. NATURE GENETICS, 2002, 32 (02) : 312 - 315
  • [9] New targets of β-catenin signaling in the liver are involved in the glutamine metabolism
    Cadoret, A
    Ovejero, C
    Terris, B
    Souil, E
    Lévy, L
    Lamers, WH
    Kitajewski, J
    Kahn, A
    Perret, C
    [J]. ONCOGENE, 2002, 21 (54) : 8293 - 8301
  • [10] P53 gene and wnt signaling in benign Neoplasms:: β-Catenin mutations in hepatic adenoma but not in focal nodular hyperplasia
    Chen, YW
    Jeng, YM
    Yeh, SH
    Chen, PJ
    [J]. HEPATOLOGY, 2002, 36 (04) : 927 - 935